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Chisholm et al have made an innovative and timely contribution towards efforts 
to scale up mental healthcare in low and middle-income countries (LMIC) 
(Chisholm et al., 2016). This paper is one output of a broader programme of 
work, ‘Emerging mental health systems in LMIC’ (Emerald), which aims to 
generate evidence and capacity to enhance health system performance in 
delivering mental health care (Semrau et al., 2015). How best to address the vast 
treatment gap for mental disorders is a major challenge for most low-resource 
settings. The dire shortage of mental health specialists, coupled with chronic 
underinvestment in mental health services by both governments and 
international donors, are key reasons for poor access to care. High levels of 
disability, mortality and human rights violations amongst people with mental 
illness are some of the consequences of this underinvestment and resulting 
treatment gap (Fekadu et al., 2015, Drew et al., 2011). The WHO’s mental health 
Gap Action Programme (mhGAP) guides the integration of mental healthcare in 
primary care. Not only does this approach address the specialist skills shortage, 
but it also represents a more efficient use of resources than the normative model 
of long-term inpatient treatment (Chisholm and Saxena, 2012). A key 
achievement of global mental health research to date is the accumulation of 
evidence that non-specialists in LMIC can provide cost-effective, feasible and 
acceptable care for a range of mental disorders (Patel et al., 2011, Chatterjee et 
al., 2014). However, there is a long road ahead before universal health coverage 
for mental illness is realised. The financing and widespread scale up of evidence-
based interventions is contingent on policy makers being aware of the 
magnitude of the task ahead, the resources required, and the potential benefits 
of such endeavours. This knowledge is essential to plan effectively for 
implementation and to prioritise how scarce resources should be used.  
 
Chisholm et al describe the development of a bespoke mental health module for 
the United Nation’s OneHealth Tool (OHT), and the application of this instrument 
to determine the resources needed to achieve target levels of coverage for three 
priority mental and neurological disorders- depression, psychosis and epilepsy- 
across six LMIC (Chisholm et al., 2016). Moreover, they have projected the 
potential health impacts, expressed as healthy life years gained, achievable with 
this investment. Chisholm et al have plainly demonstrated that with small 
investments in mental healthcare substantial health benefits could be attained. 
In the low-income countries included in this study- Ethiopia, Uganda and Nepal- 
annual expenditure of US$ 0.34-1.27 per capita of total population at target 
coverage levels could translate into 755 to 947 healthy life years gained per one 
million population in the final year of each country’s projection. Yet whilst the 
resources needed are small in absolute terms, they represent a significant 
increase compared to current expenditure which sits between US$ 0.11- 0.33 at 
baseline levels of coverage for the three low-income countries. 
 
The implications of these findings for global mental health are clear. First, there 
is an on-going need for cost-effective mental health interventions to be 
developed and evaluated in LMIC. There are exciting developments in the 
evaluation of interventions for psychosis, depression and epilepsy in the 
Emerald countries and other LMICs using randomised (Asher et al., 2016, Hanlon 
et al., 2016, Chibanda et al., 2015) and non-randomised designs (De Silva et al., 
2016), but such evaluations still remain the exception rather than the rule. The 
attention of researchers should also turn to the challenges of implementation, 
rather than simply evaluation in relatively small-scale trials (Thornicroft, 2012). 
A separate Emerald work stream will use a mixed methods approach to 
investigate the implementation of mhGAP in six LMICs (Semrau et al., 2015). 
Second, advocacy efforts to encourage sustained political commitment to mental 
health, particularly in the face of numerous competing demands, remain 
paramount (Hendler et al., 2016). Third, policy makers in LMIC must be 
equipped with appropriate analytical tools to make mental health resource 
needs assessments in the context of their wider national health plans, and in 
particular to be able to forecast the benefits of increases in investment. Indeed 
the broader value of the work presented by Chisholm et al lies in the public 
availability of the mental health module of the OHT; the authors anticipate that 
the tool will be used by health planners and health system researchers in other 
settings.  
 
It is widely acknowledged that progressive realisation is the approach required 
for most countries expanding mental health services, in terms of population 
coverage and also with regard to which interventions are offered and which 
conditions are addressed (Patel, 2015). Setting interim targets for treatment 
coverage that are merely ambitious, rather than frankly unrealistic, is a key 
challenge. Chisholm et al present scale up periods of between five and seven 
years, selected by country partners, and there is evidently some pragmatism in 
the target coverage levels chosen. However, in some cases there are striking 
differences between the extremely low baseline coverage and the target 
coverage. For example in Ethiopia the target coverage (10%) for each of three 
interventions for depression, including ‘intensive psychosocial treatment and 
anti-depressant medication of first episode moderate-severe cases’, a one 
hundred fold increase from baseline coverage (0.1%) is required. It remains to 
be seen if such huge changes can practically be achieved within a seven-year 
period, and therefore whether the projected health impacts can be realised. 
Whilst contact coverage refers to the proportion of persons in need of a service 
who actually receive an appropriate intervention, effective coverage is defined as 
‘the probability that individuals will receive health gain from an intervention if 
they need it’ (De Silva et al., 2014). Increased effective coverage of mental health 
interventions is the ultimate goal of scale-up efforts, but there are several 
potential barriers to achieving this in LMIC.  
 
First, whilst non-specialists can deliver effective mental health interventions in a 
trial setting, there is limited experience worldwide of task shifting at scale.  
Several challenges will need to be surmounted including the logistical issues of 
training and supervising vast numbers of primary care staff and community 
health workers to deliver high-quality and effective care in the long term (Patel, 
2015, Hanlon et al., 2016). Second is the issue of acceptability of the proposed 
mental health interventions, without which engagement, and therefore 
treatment response, is likely to be poor. Several approaches have been identified 
to increase the acceptability, and therefore demand, for psychological therapies 
in LMIC (Patel et al., 2011); for example, in Pakistan a psychological therapy for 
perinatal depression focused on infant health and development, rather than 
depression, to increase acceptability to participants (Rahman, 2007). The 
importance of addressing the broader social needs of service users in LMIC, in 
particular through supporting livelihoods, has also been highlighted (Kidd et al., 
2016, Lund et al., 2011, Patel, 2015, Patel et al., 2011); whether these more 
intensive approaches can be scaled up has received little attention to date. The 
troublesome side effect profile of first generation anti-psychotics, which are 
recommended by mhGAP, may threaten medication adherence rates. Third is the 
issue of the affordability of mental healthcare. In order to promote equitable 
access, governments should ensure that costs are met by financial protection 
measures such as health insurance schemes (Patel et al., 2015). This is 
particularly important given the chronic nature of many mental disorders and 
the heavy financial burden on families due to treatment costs and loss of 
productivity. Whilst some of the countries included in Chisholm et al’s analysis 
provide free psychotropic medication (Hanlon et al., 2014), in Ethiopia, as in 
many other LMICs, there are no health insurance schemes and psychotropic 
medications costs are borne directly by service users. This may prove to be a 
critical barrier to people with mental illness receiving services as intended.   
 
An important strength of the mental health module of the OHT is the ability to 
easily compare estimated costs and health impacts across disorders. It can be 
discerned that the greatest benefits, in terms of healthy life years gained, are 
obtainable through implementing interventions for depression and epilepsy, 
compared to psychosis. However, as previously noted by Chisholm, other factors 
should also be taken into account by policy makers when priority setting, 
including the impact on productivity and human rights, and the financial 
implications for the household (Chisholm and Saxena, 2012, Strand et al., 2016). 
The prominence of these issues in relation to psychosis lends support for it to 
remain a priority disorder for investment. The economic impact of mental 
disorders is another area of investigation of the Emerald work programme using 
detailed household surveys in the six participating countries (Semrau et al., 
2015). In future it is possible this information will also contribute to priority 
setting across mental disorders. 
 
A further strength Chisholm et al’s paper is the extensive collaboration with 
policy makers and planners in each of the six LMICs. This directly challenges the 
assertion that efforts to improve mental health in LMIC naturally have an 
imperialist flavour, in which a Western biomedical agenda is imposed upon 
unwilling and unequal participants (White and Sashidharan, 2014, Summerfield, 
2013). Furthermore, utilising highly contextualised estimates of available human 
resources, costs, likely efficacy, and adherence to interventions, as well as 
tailoring target coverage to the setting, undoubtedly increases the accuracy of 
data. The results are also more likely to be useful to, and therefore used by, 
national policy makers. This work also acted as a capacity building exercise, from 
which country partners can go on to independently refine projections as more 
information becomes available or to add other disorders, for example alcohol 
dependence in South Africa.   
 
It is clear that increased funding for mental healthcare is sorely needed in most 
LMIC. Chisholm et al have demonstrated that a little investment could go a long 
way in terms of health benefits. Some have called for a global mental health fund 
to rival the Global Fund to Fight AIDS, Tuberculosis, and Malaria; such a fund, it 
is proposed, would support access to free anti-psychotic medication and 
psychosocial support across LMIC (Farooq et al., 2016). Whilst this is a laudable 
appeal, sustained commitment from governments to invest in scaling up mental 
healthcare is needed first and foremost, not least because such a fund is unlikely 
to materialise in the near future. Others have proposed that governments use 
funds raised from increased income tax on unhealthy products, for example 
tobacco, or divert expenditure from non-evidence based interventions, such as 
multivitamins, to mental health (Patel et al., 2015). Whilst increased funding may 
be slow to emerge, the mental health module of the OHT is at least an important 
first step supporting the widespread funding for, and implementation of, mental 
health interventions in LMIC.  
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